lifestyle.thedishh.com

Author: RazorPitch

Market Signals Highlight Next Wave of Immunotherapy Growth (OSTX, IBRX)

December 17, 2025
Actinium Pharmaceuticals Advances Trop-2 Targeted Alpha Radiotherapy Into Phase 1/2 Trials in the U.S. and Australia

December 12, 2025
Actinium Pharmaceuticals (NYSEAMERICAN: ATNM) Begins European Phase 1 Trial of Nectin-4 Targeted Alpha Therapy for Multiple Solid Tumors

December 10, 2025
FDCTech, Inc. (OTC: FDCT) Poised to Capitalize on the Retail Trading Boom

December 10, 2025
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Advances ATNM-400 Targeting STEAP-1 Across Prostate, Breast, and Lung Cancer

December 9, 2025
ATNM-400 Targets B7-H3 and Is Being Studied in a Phase 1 Clinical Trial in South Africa

December 8, 2025
Actinium Pharmaceuticals Advances ATNM-400 B7-H3 Candidate Into Phase 1 Clinical Trial in South Africa

December 8, 2025
Aether Holdings, Inc. (NASDAQ: ATHR) Targets $28B AI Analytics Market With a Data-Media Ecosystem Strategy

December 5, 2025
Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch

December 5, 2025
Drone Surveying Set to Grow from $1.97B to $11.49B by 2035 as ZenaTech, Inc. (NASDAQ: ZENA) Expands Its U.S. Footprint

December 4, 2025